http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9409972-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c106db0979c9cdaf8c12ab35afa23b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e9aee13868bfedebe2df1f13cda5490
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47
filingDate 2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1be53cc65fc9d95c34f305e6f18ba1e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f892bb5adbfc5a82f8ec248de9ebea44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f38ab82df9328821c470643353848f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_302b39f9658ed365890399dddc7dc688
publicationDate 2016-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9409972-B2
titleOfInvention Pharmaceutical composition and method of preparing same
abstract An object of the present invention is to provide a pharmaceutical composition comprising an enzyme-treated human serum which is useful for treatment and prevention of diseases such as a cancer and an infectious disease, and a method of preparing the same. The present invention relates to a method of preparing a pharmaceutical composition comprising an enzyme-treated human serum, comprising a step of bringing the human serum into contact with β-galactosidase and, to a pharmaceutical composition comprising an enzyme-treated human serum obtained by the preparation method.
priorityDate 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004224877-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012029954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0597695-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0699314-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2612921-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11586781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226913413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID240208087

Total number of triples: 34.